Company Filing History:
Years Active: 2001-2002
Title: Christopher P. Beganski: Innovator in Biologically Active Agents
Introduction
Christopher P. Beganski is a notable inventor based in Littleton, MA (US). He has made significant contributions to the field of biologically active agents, holding 2 patents that showcase his innovative approaches.
Latest Patents
His latest patents focus on the method of producing sub-micron particles of biologically active agents. This process involves atomizing a dispersed system containing at least one biologically active agent and a solvent to create droplets. These droplets are then frozen and lyophilized to obtain microstructures that can be fragmented into submicron particles using techniques such as probe sonication. The resulting submicron particles can be incorporated into sustained release compositions, which are designed to have a reduced initial release of the biologically active agent. These compositions can be administered to humans or animals, highlighting their potential therapeutic applications.
Career Highlights
Christopher P. Beganski is associated with Alkermes Controlled Therapeutics, Inc., where he continues to advance his research and development efforts. His work is pivotal in the field of drug delivery systems, particularly in enhancing the efficacy of biologically active agents.
Collaborations
He has collaborated with notable colleagues such as Henry R. Costantino and Warren E. Jaworowicz, contributing to a dynamic research environment that fosters innovation.
Conclusion
Christopher P. Beganski's contributions to the field of biologically active agents through his patents and collaborations underscore his role as a key innovator. His work continues to impact the development of advanced therapeutic solutions.